Asad
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Ghaziabad 'Bakrid invite' murder: Main accused Asad shot dead in encounter
GHAZIABAD: The prime accused in the fatal stabbing of a Class 11 student in Ghaziabad was shot dead in a police encounter late on Saturday night. Officials said the accused, Asad, was wanted in connection with the killing of 17-year-old Surya Pratap, who was stabbed during an altercation in Khoda Colony on Thursday evening and succumbed to injuries on Friday afternoon. According to police, Asad was planning to meet associates in the Khoda police station area and allegedly intended to flee...
'Began firing indiscriminately': How UP police gunned down key accused in Ghaziabad teen murder
GHAZIABAD: A 17-year-old murder accused carrying a reward of Rs 50,000 was killed in an encounter with police in Ghaziabad’s Khoda Colony in the early hours of Sunday, officials said. The accused, identified as Asad, a resident of Khoda Colony, was wanted in connection with the stabbing death of a teenager earlier this week. According to police, officers from Khoda and Indirapuram stations received specific input from an informer that Asad, the prime accused in the case, had been spotted on...
'Bakra halal hote dekha hai, aao dikhate hain ... ': Ghaziabad teen stabbed to death
A 17-year-old boy, Surya Pratap, died after being stabbed multiple times by his friend Asad in Ghaziabad's Khoda Colony. The incident occurred following an argument, with the accused fleeing the scene. Police are investigating the motive and have formed teams to apprehend Asad.
Pakistan Outlines 4% Growth Target For Next Fiscal Year
An Iron re-rolling mill in Islamabad. Photographer: Asad Zaidi/Bloomberg
This drug delayed rheumatoid arthritis for years after treatment ended
This drug delayed rheumatoid arthritis for years after treatment ended - Date: - June 1, 2026 - Source: - King's College London - Summary: - A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk. Researchers found that just one year of treatment with the immune-targeting drug abatacept delayed the onset of rheumatoid arthritis by up to four years, with benefits lasting long after treatment ended. - Share: People at high risk of...